COVAXIN, Covishield effective, but produce fewer antibodies against B.1.617: Report

According to a series of early reports authored by scientists at the Indian Council of Medical Research (ICMR), COVAXIN and Covishield—vaccines deemed effective at generating an immune response against COVID-19—appear to generate only half as many antibodies against the B.1.617 variant. The scientists said this reduced ability to generate antibodies does not diminish the fact that the vaccines continue to be effective against COVID-19.

source https://www.newsbytesapp.com/news/india/covaxin-covishield-produce-fewer-antibodies-against-b-1-167-strain/story